Global Markets for Emerging Insulin Drug and Delivery Technologies

NEW YORK, Aug. 19, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Markets for Emerging Insulin Drug and Delivery Technologies
http://www.reportlinker.com/p01598546/Global-Markets-for-Emerging-Insulin-Drug-and-Delivery-Technologies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply

This study encompasses insulin drugs and delivery in pharmaceutical and biotechnology markets with its classification and its usage in diabetes types. The study includes market projections through the end of 2013 and for a five-year period until 2018.

Highlights

- The global market for insulin drug and delivery devices totaled $24 billion in 2012. The overall insulin drug and device market is projected to be worth $25.7 million by 2013 and $40.2 billion by 2018, a five-year compound annual growth rate (CAGR) for of 9.3% from 2013 to 2018.
- The insulin vial and syringe segment had a market value of $13.7 billion in 2012. It is expected to reach $14.7 billion by 2013 and $23.3 billion by 2018 with a CAGR of 9.6%. - The insulin pens market totaled nearly $9.4 billion in 2012. This market is expected to reach $10 billion in 2013 and $15.4 billion by 2018, a CAGR of 8.9%.

STUDY OBJECTIVES

BCC Research's objective in carrying out this study is to provide an overview of the current and future characteristics of the global market for emerging insulin drugs and delivery technologies. The fundamental objective is to present a comprehensive analysis and identify the future direction of insulin drugs and delivery devices as important tools in treating diabetes with well-tolerated delivery devices. This report explores present and future strategies within the insulin drug and delivery market, which includes syringes, pumps, pens and many newer methods. The market's improvisation, setbacks and needs are also discussed. The classifications, comparisons and usage of different insulin types and devices are presented as well.
A detailed analysis of insulin drugs and delivery industry structure has been conducted. Revenues are broken down by type, as well as by region. Sales figures are estimated for the five-year period from 2013 through 2018. Applications for insulin drugs and delivery are also discussed in a separate section, with emphasis on their usage in treating different types of diabetes. The report also covers significant patents and their allotments in each category.

REASONS FOR DOING THIS STUDY

The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles. , leading to a steady market for these technologies.
Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future. This study looks at many of the systems affected by these factors. Companies' acquisition strategies and collaborations are covered in this report. This study also discusses the strength and weaknesses of each technology type in light of the new technologies, growing competition and changing customer needs.

CONTRIBUTIONS OF THE STUDY AND FOR WHOM

This study contributes to the areas of market growth for insulin drug and delivery manufacturers and users. It will be of interest to pharmaceutical biotechnical companies, research institutes, hospitals and physicians.

SCOPE OF THE STUDY

The scope of this study encompasses insulin drugs and delivery in pharmaceutical and biotechnology markets with its classification and its usage in diabetes types. BCC analyzes each market and its applications, as well as its regulatory environment, technology and market share. The markets, such as type 1 diabetes, type 2 diabetes and gestational diabetes, are analyzed for the years 2011 and 2012. The markets are projected through the end of 2013 and for a five-year period until 2018. The market is also segmented by insulin syringes and vials, insulin pens and insulin pumps. Technological issues include the latest trends and developments. The study also includes the patent identifications for insulin as a drug, along with its deliveries.
The emerging markets for insulin drug and delivery include India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.

METHODOLOGY

Both primary and secondary research methodologies were used in the preparation of this study. BCC Research conducted a comprehensive literature search, which included technical newsletters and journals, as well as many other sources. Data were collected through interviews and correspondence with manufacturers of enzyme inhibitors technical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

CHAPTER 1 INTRODUCTION 2

STUDY OBJECTIVES 2
REASONS FOR DOING THIS STUDY 2
CONTRIBUTIONS OF THE STUDY AND FOR WHOM 2
SCOPE OF THE STUDY 3
METHODOLOGY 3
INFORMATION SOURCES 3
ABOUT THE AUTHOR 3
RELATED BCC RESEARCH REPORTS 4
BCC ONLINE SERVICES 4
DISCLAIMER 4

CHAPTER 2 SUMMARY 6

SUMMARY TABLE GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET,
THROUGH 2018 ($ MILLIONS) 7
SUMMARY FIGURE GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET,
2011-2018 ($ MILLIONS) 8

CHAPTER 3 OVERVIEW 10

DIABETES OVERVIEW 10
DIABETES CLASSIFICATION 10
TABLE 1 DISTINGUISHING FEATURES OF TYPE 1 AND TYPE 2 DIABETES 11
EPIDEMIOLOGY 13
TABLE 2 ESTIMATED DIABETES CASES IN 2030 AND POPULATION CHANGES WITH
RESPECT TO 2000 13
TYPE 1 DIABETES MELLITUS MANAGEMENT 14
INSULIN 15
HISTORY OF INSULIN ISOLATION AND THE DEVELOPMENT OF ITS ANALOGS 15
TABLE 3 HISTORY OF INSULIN ISOLATION AND DEVELOPMENT 15
STRUCTURE OF INSULIN 16
INSULIN BIOSYNTHESIS 16
INSULIN TYPES 17
TABLE 4 CHARACTERISTIC PROPERTIES OF VARIOUS INSULIN FORMULATIONS 19
TREATMENT PROTOCOL 20
Multiple Daily Injections 20
TABLE 5 ADVANTAGES AND DISADVANTAGES OF SYRINGES 21
Continuous Subcutaneous Insulin Infusion and Insulin Pump Therapy 21
TABLE 6 INSULIN PUMPS CURRENTLY ON THE MARKET 22
TABLE 7 COMPARATIVE DEPICTION OF RISK VERSUS BENEFIT FEATURES FOR
VARIOUS INSULIN DELIVERY SYSTEMS 23
TABLE 8 INSULIN PENS CURRENTLY ON THE MARKET 25
ADMINISTRATION ROUTES 26
TABLE 9 INSULIN ADMINISTRATION ROUTES 26

CHAPTER 4 REGULATORY ASPECTS 29

APPROVALS FOR INSULIN DRUGS 29
TABLE 10 INSULIN DRUG APPROVALS, 2009–MARCH 2013 29
APPROVALS GRANTED FOR INSULIN DEVICES 30
TABLE 11 PREMARKET APPROVAL SUPPLEMENTAL APPROVALS FOR INSULIN
DEVICES, 2009–MARCH 2013 30
PREMARKET NOTIFICATION OR 510(K) CLEARANCE 32
TABLE 12 PREMARKET NOTIFICATION OR 510 (K) CLEARANCES FOR INSULIN
DEVICES, 2009–MARCH 2013 33
SAFETY ALERTS AND RECALLS 34
TABLE 13 SAFETY ALERTS FOR INSULIN DRUGS AND DEVICES, 2009–APRIL 2013 34
TABLE 14 DRUG RECALLS FOR INSULIN DRUGS AND DEVICES, 2009–APRIL 2013 35

CHAPTER 5 NEW DEVELOPMENTS 41

NEW TECHNOLOGIES FOR INSULIN DELIVERY 42
INSULIN INHALERS 42
INSULIN SPRAY 42
IMPLANTABLE INSULIN PUMPS 42
TRANSDERMAL PATCH 42
PRODUCT DEVELOPMENT 43
TABLE 15 NEW DEVELOPMENTS FOR INSULIN DRUGS AND DELIVERY DEVICES 43
MERGERS AND ACQUISITIONS 45
TABLE 16 INSULIN DRUG AND DELIVERY DEVICE COMPANY MERGERS AND
ACQUISITIONS 46
LICENSING, PARTNERSHIPS, AND AGREEMENTS 47
TABLE 17 LICENSING, PARTNERSHIPS, AND AGREEMENTS FOR INSULIN DRUGS
AND DELIVERY DEVICES 48
PIPELINE PRODUCTS 51
TABLE 18 INSULIN DRUG AND DELIVERY DEVICE PIPELINE PRODUCTS 51

CHAPTER 6 GLOBAL MARKETS 56

MARKET BY TYPE 57
MARKET OVERVIEW 57
MARKET REVENUE 58
TABLE 19 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE,
THROUGH 2018 ($ MILLIONS) 58
FIGURE 1 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE,
2011-2018 ($ MILLIONS) 59
MARKET SHARE 59
TABLE 20 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY TYPE, 2012
(%) 59
FIGURE 2 INSULIN DRUG AND DEVICE MARKET SHARES BY TYPE, 2012 (%) 60
MARKET BY REGION 60
MARKET OVERVIEW 61
MARKET REVENUE 62
TABLE 21 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION,
THROUGH 2018 ($ MILLIONS) 62
FIGURE 3 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION,
2011–2018 ($ MILLIONS) 63
MARKET SHARE 63
TABLE 22 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARE BY REGION, 2012
(%) 63
FIGURE 4 INSULIN DRUG AND DEVICE MARKET SHARE BY REGION, 2012 (%) 63
INSULIN SYRINGES AND VIALS 64
Market Overview 64
Market Revenue 64
TABLE 23 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 65

FIGURE 5 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, 2011-2018 ($
MILLIONS) 65
Market Share 65
TABLE 24 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 66
FIGURE 6 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 66
INSULIN PENS 66
Market Overview 67
Market Revenue 67
TABLE 25 GLOBAL INSULIN PEN MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 68
FIGURE 7 GLOBAL INSULIN PEN MARKET BY REGION, 2011–2018 ($ MILLIONS) 68
Market Share 68
TABLE 26 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 69
FIGURE 8 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 69
INSULIN PUMPS 69
Market Overview 70
Market Revenue 71
TABLE 27 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 71
FIGURE 9 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 72

Market Share 72
TABLE 28 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 72
FIGURE 10 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 72
MARKET BY APPLICATIONS 73
TYPE 1 DIABETES 73
TYPE 2 DIABETES 74
GESTATIONAL DIABETES 75
MARKET OVERVIEW 75
MARKET REVENUE 76
TABLE 29 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION,
THROUGH 2018 ($ MILLIONS) 76
FIGURE 11 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY
APPLICATION, 2011–2018 ($ MILLIONS) 76
MARKET SHARE 77
TABLE 30 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION,
2012 (%) 77
FIGURE 12 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY
APPLICATION, 2012 (%) 77

CHAPTER 7 INSULIN SYRINGE AND VIAL MARKET ANALYSIS 80

MARKET BY TYPE 80
U-100 INSULIN SYRINGE 81
U-40 INSULIN SYRINGES 81
MARKET OVERVIEW 81
MARKET REVENUE FOR INSULIN SYRINGES 82
TABLE 31 GLOBAL INSULIN SYRINGE MARKET BY TYPE, THROUGH 2018 ($
MILLIONS) 82
FIGURE 13 GLOBAL INSULIN SYRINGE MARKET BY TYPE, 2011–2018 ($ MILLIONS) 82
INSULIN SYRINGE MARKET SHARE 83
TABLE 32 INSULIN SYRINGE MARKET SHARES BY TYPE, 2012 (%) 83
FIGURE 14 INSULIN SYRINGE MARKET SHARES BY TYPE, 2012 (%) 83
INSULIN SYRINGE AND VIAL MARKET REVENUE 84
TABLE 33 GLOBAL INSULIN SYRINGE AND VIAL MARKET, THROUGH 2018 ($
MILLIONS) 84
FIGURE 15 GLOBAL INSULIN SYRINGE AND VIAL MARKET, 2011–2018 ($ MILLIONS) 84
INSULIN SYRINGE AND VIAL MARKET SHARES 85
TABLE 34 INSULIN SYRINGE AND VIAL MARKET SHARES BY TYPE, 2012 (%) 85
FIGURE 16 INSULIN SYRINGE AND VIAL MARKET SHARES BY TYPE, 2012 (%) 85

MARKET BY REGION 86
MARKET OVERVIEW 86
INSULIN SYRINGE MARKET REVENUE 86
TABLE 35 GLOBAL INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 87
FIGURE 17 GLOBAL INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 87
U-100 Insulin Syringe Market Revenue 87
TABLE 36 GLOBAL U-100 INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 88
FIGURE 18 GLOBAL U-100 INSULIN SYRINGE MARKET BY REGION, 2011–2018 ($
MILLIONS) 88
U-40 Insulin Syringe Market Revenue 88
TABLE 37 GLOBAL U-40 INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 89
FIGURE 19 GLOBAL U-40 INSULIN SYRINGE MARKET BY REGION, 2011–2018 ($
MILLIONS) 89
INSULIN SYRINGE AND VIAL MARKET REVENUE 90
TABLE 38 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 90
FIGURE 20 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH

2018 ($ MILLIONS) 91
INSULIN SYRINGE MARKET SHARES 91
TABLE 39 INSULIN SYRINGE MARKET SHARES BY REGION, 2012 (%) 91
FIGURE 21 INSULIN SYRINGE MARKET SHARES BY REGION, 2012 (%) 91
INSULIN SYRINGE AND VIAL MARKET SHARES 92
TABLE 40 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 92
FIGURE 22 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 92
MARKET BY APPLICATION 93
TYPE 1 DIABETES 93
TYPE 2 DIABETES 94
GESTATIONAL DIABETES 94
MARKET OVERVIEW 94
MARKET REVENUE FOR SYRINGES 95
TABLE 41 INSULIN SYRINGE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS) 95
FIGURE 23 INSULIN SYRINGE MARKET BY APPLICATION, 2011–2018 ($ MILLIONS) 96
SYRINGE MARKET SHARES 96
TABLE 42 INSULIN SYRINGE MARKET SHARES BY APPLICATION, 2012 (%) 96
FIGURE 24 INSULIN SYRINGE MARKET SHARES BY APPLICATION, 2012 (%) 96
SYRINGE AND VIAL MARKET REVENUE 97
TABLE 43 INSULIN SYRINGE AND VIAL MARKET BY APPLICATION, THROUGH 2018 ($
MILLIONS) 98
FIGURE 25 INSULIN SYRINGE AND VIAL MARKET BY APPLICATION, 2011–2018 ($
MILLIONS) 98
SYRINGE AND VIAL MARKET SHARES 98
TABLE 44 INSULIN SYRINGE AND VIAL MARKET SHARES BY APPLICATION, 2012 (%) 99
FIGURE 26 INSULIN SYRINGE AND VIAL MARKET SHARES BY APPLICATION, 2012 (%) 99
INDUSTRY STRUCTURE 99
MARKET LEADERS 100

TABLE 45 LEADING MANUFACTURERS AND SUPPLIERS OF INSULIN SYRINGES AND
VIALS 100
INSULIN SYRINGE MARKET SHARES 101
TABLE 46 INSULIN SYRINGE MANUFACTURER MARKET SHARES, 2012 (%) 101
FIGURE 27 INSULIN SYRINGE MANUFACTURER MARKET SHARES, 2012 (%) 101
INSULIN SYRINGE AND VIAL MARKET SHARES 102
TABLE 47 INSULIN SYRINGE AND VIAL MANUFACTURER MARKET SHARES, 2012 (%) 102
FIGURE 28 INSULIN SYRINGE AND VIAL MANUFACTURER MARKET SHARES, 2012 (%) 103

CHAPTER 8 INSULIN PEN MARKET ANALYSIS 105

MARKET BY TYPE 105
MARKET OVERVIEW 106
MARKET REVENUE 106
TABLE 48 GLOBAL INSULIN PEN MARKET BY TYPE, THROUGH 2018 ($ MILLIONS) 106
FIGURE 29 GLOBAL INSULIN PEN MARKET BY TYPE, THROUGH 2018 ($ MILLIONS) 106
MARKET SHARE 107
TABLE 49 INSULIN PEN MARKET SHARES BY TYPE, 2012 (%) 107
FIGURE 30 INSULIN PEN MARKET SHARES BY TYPE, 2012 (%) 107
MARKET BY REGION 108
MARKET OVERVIEW 108
MARKET REVENUE 109
TABLE 50 GLOBAL INSULIN PEN MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 109
FIGURE 31 GLOBAL INSULIN PEN MARKET BY REGION, 2011–2018 ($ MILLIONS) 110
DURABLE OR REUSABLE INSULIN PENS 110
Market Overview 110
Market Revenue 111
TABLE 51 GLOBAL DURABLE OR REUSABLE INSULIN PEN MARKET BY REGION,
THROUGH 2018 ($ MILLIONS) 111

FIGURE 32 GLOBAL DURABLE OR REUSABLE INSULIN PEN MARKET BY REGION,
THROUGH 2018 ($ MILLIONS) 111
DISPOSABLE INSULIN PENS 112
Market Overview 112
Market Revenue 113
TABLE 52 GLOBAL DISPOSABLE INSULIN PEN MARKET BY REGION, THROUGH 2018
($ MILLIONS) 113
FIGURE 33 GLOBAL DISPOSABLE INSULIN PEN MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 114
MARKET SHARE 114
TABLE 53 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 114
FIGURE 34 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 114
MARKET BY APPLICATIONS 115
TYPE 1 DIABETES 115
TYPE 2 DIABETES 116
GESTATIONAL DIABETES 116
MARKET OVERVIEW 116
MARKET REVENUE 117
TABLE 54 INSULIN PEN MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS) 117
FIGURE 35 INSULIN PEN MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS) 117

MARKET SHARE 118
TABLE 55 INSULIN PEN MARKET SHARES BY APPLICATION, 2012 (%) 118
FIGURE 36 INSULIN PEN MARKET SHARES BY APPLICATION, 2012 (%) 118
INDUSTRY STRUCTURE 118
MARKET LEADERS 119
TABLE 56 LEADING INSULIN PEN MANUFACTURERS AND SUPPLIERS 119
MARKET SHARES 120
TABLE 57 INSULIN PEN MANUFACTURER MARKET SHARES, 2012 (%) 120
FIGURE 37 INSULIN PEN MANUFACTURER MARKET SHARES, 2012 (%) 121

CHAPTER 9 INSULIN PUMP MARKET ANALYSIS 123

MARKET BY TYPE 123
MARKET OVERVIEW 124
MARKET REVENUE 125
TABLE 58 GLOBAL INSULIN PUMP MARKET BY TYPE, THROUGH 2018 ($ MILLIONS) 125
FIGURE 38 GLOBAL INSULIN PUMP MARKET BY TYPE, THROUGH 2018 ($ MILLIONS) 126
MARKET SHARE 126
TABLE 59 INSULIN PUMP MARKET SHARES BY TYPE, 2012 (%) 126
FIGURE 39 INSULIN PUMP MARKET SHARES BY TYPE, 2012 (%) 126
MARKET BY REGION 127
MARKET OVERVIEW 127
MARKET REVENUE 128
TABLE 60 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 128
FIGURE 40 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 128
INSULIN PUMPS WITH TUBING 129
Market Overview 129
Market Revenue 130
TABLE 61 GLOBAL INSULIN PUMPS WITH TUBING MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 131

FIGURE 41 GLOBAL INSULIN PUMPS WITH TUBING MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 131
TUBELESS INSULIN PUMPS 131
Market Overview 132
Market Revenue 133
TABLE 62 GLOBAL TUBELESS INSULIN PUMP MARKET BY REGION, THROUGH 2018
($ MILLIONS) 133
FIGURE 42 GLOBAL TUBELESS INSULIN PUMP MARKET BY REGION, 2011–2018 ($
MILLIONS) 133
IMPLANTABLE INSULIN PUMPS 134
Market Overview 134
Market Revenue 136
TABLE 63 GLOBAL IMPLANTABLE INSULIN PUMP MARKET BY REGION, THROUGH

2018 ($ MILLIONS) 136
FIGURE 43 GLOBAL IMPLANTABLE INSULIN PUMP MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 136
MARKET SHARE 137
TABLE 64 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 137
FIGURE 44 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 137
MARKET BY APPLICATIONS 138
TYPE 1 DIABETES 138
TYPE 2 DIABETES 139
GESTATIONAL DIABETES 140
MARKET OVERVIEW 140
MARKET REVENUE 140
TABLE 65 GLOBAL INSULIN PUMP MARKET BY APPLICATION, THROUGH 2018 ($

MILLIONS) 141
FIGURE 45 GLOBAL INSULIN PUMP MARKET BY APPLICATION, THROUGH 2018 ($
MILLIONS) 141
MARKET SHARE 142
TABLE 66 INSULIN PUMP MARKET SHARES BY APPLICATION, 2012 (%) 142
FIGURE 46 INSULIN PUMP MARKET SHARES BY APPLICATION, 2012 (%) 142
INDUSTRY STRUCTURE 142
MARKET LEADERS 143
TABLE 67 LEADING MANUFACTURERS AND SUPPLIERS OF INSULIN PUMPS 143
MARKET SHARES 144
TABLE 68 INSULIN PUMP MANUFACTURER MARKET SHARES, 2012 (%) 144
FIGURE 47 INSULIN PUMP MANUFACTURER MARKET SHARES, 2012 (%) 144

CHAPTER 10 PATENT ANALYSIS 147

PATENTS BY YEAR 147
TABLE 69 U.S. PATENTS, JANUARY 2009–MARCH 2013 (%) 147
FIGURE 48 U.S. PATENTS, JANUARY 2009–MARCH 2013 (%) 147
PATENTS BY TYPE 148
TABLE 70 U.S. INSULIN PATENTS BY TYPE, JANUARY 2009–MARCH 2013 148
FIGURE 49 U.S. INSULIN PATENTS BY TYPE, JANUARY 2009–MARCH 2013 148
PATENTS BY COMPANY 149
TABLE 71 U.S. PATENTS BY COMPANY, JANUARY 2009–MARCH 2013 149
PATENTS BY COUNTRY 151
TABLE 72 U.S. PATENTS BY COUNTRY, JANUARY 2009–MARCH 2013 151
FIGURE 50 U.S. PATENTS BY COUNTRY, JANUARY 2009–MARCH 2013 152
PATENTS BY ASSIGNEE 152
TABLE 73 U.S. PATENTS BY ASSIGNEE, JANUARY 2009–MARCH 2013 152
FIGURE 51 U.S. PATENTS BY ASSIGNEE, JANUARY 2009–MARCH 2013 152

CHAPTER 11 CURRENT SITUATION 155

MARKET TRENDS 156
INSULIN PUMPS 156
Artificial Pancreas 156
Closed-Loop Insulin Pump 156
INSULIN PENS 157
INSULIN SYRINGES 157
MODERN INSULIN AND ALTERNATIVE DELIVERY METHODS 157
ORAL INSULIN 157
NASAL INSULIN SPRAY 158
BIOSIMILAR INSULIN 158
OVERALL MARKET DRIVERS FOR INSULIN DELIVERY DEVICE MARKET 158
FACTORS GOVERNING THE INSULIN DELIVERY DEVICE MARKET 159
COLLABORATIONS, MERGERS AND AQUISITIONS 159
CHAPTER 12 COMPANY PROFILES 163
ADOCIA 163
ANIMAS CORPORATION 163
ANTRIABIO 164
BECTON, DICKINSON AND COMPANY 165
BIOCON LIMITED 165
BIODEL INC. 166
DEBIOTECH 167
ELI LILLY 167
ETERNITY HEALTHCARE 168
F. HOFFMANN-LA ROCHE LTD. (DISETRONIC MEDICAL SYSTEMS AG) 169
GENEREX BIOTECHNOLOGY CORPORATION 169
HALOZYME THERAPEUTICS INC. 170
INSULINE MEDICAL 170
INSULUTION ABM 171
LIFESCAN 171
MANNKIND 172
MARINA BIOTECH INC. 173
MEDTRONIC INC. 174
MICROPORT SCIENTIFIC CORPORATION 174
MIDASOL THERAPEUTICS (JOINT VENTURE OF MIDATECH LTD. AND MONOSOL
RX) 175
NOVO NORDISK 175
ORAMED PHARMACEUTICALS INC. 176
PHOSPHAGENICS LIMITED 177
SANOFI 177
SENSILE MEDICAL AG 178
THERMALIN DIABETES INC. 179
XERIS PHARMACEUTICALS 180
YPSOMED HOLDING AG 180

LIST OF TABLES

SUMMARY TABLE GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET,
THROUGH 2018 ($ MILLIONS) 7
TABLE 1 DISTINGUISHING FEATURES OF TYPE 1 AND TYPE 2 DIABETES 11
TABLE 2 ESTIMATED DIABETES CASES IN 2030 AND POPULATION CHANGES WITH
RESPECT TO 2000 13
TABLE 3 HISTORY OF INSULIN ISOLATION AND DEVELOPMENT 15
TABLE 4 CHARACTERISTIC PROPERTIES OF VARIOUS INSULIN FORMULATIONS 19
TABLE 5 ADVANTAGES AND DISADVANTAGES OF SYRINGES 21
TABLE 6 INSULIN PUMPS CURRENTLY ON THE MARKET 22
TABLE 7 COMPARATIVE DEPICTION OF RISK VERSUS BENEFIT FEATURES FOR
VARIOUS INSULIN DELIVERY SYSTEMS 23
TABLE 8 INSULIN PENS CURRENTLY ON THE MARKET 25
TABLE 9 INSULIN ADMINISTRATION ROUTES 26
TABLE 10 INSULIN DRUG APPROVALS, 2009–MARCH 2013 29
TABLE 11 PREMARKET APPROVAL SUPPLEMENTAL APPROVALS FOR INSULIN
DEVICES, 2009–MARCH 2013 30
TABLE 12 PREMARKET NOTIFICATION OR 510 (K) CLEARANCES FOR INSULIN
DEVICES, 2009–MARCH 2013 33
TABLE 13 SAFETY ALERTS FOR INSULIN DRUGS AND DEVICES, 2009–APRIL 2013 34
TABLE 14 DRUG RECALLS FOR INSULIN DRUGS AND DEVICES, 2009–APRIL 2013 35
TABLE 15 NEW DEVELOPMENTS FOR INSULIN DRUGS AND DELIVERY DEVICES 43
TABLE 16 INSULIN DRUG AND DELIVERY DEVICE COMPANY MERGERS AND
ACQUISITIONS 46
TABLE 17 LICENSING, PARTNERSHIPS, AND AGREEMENTS FOR INSULIN DRUGS AND
DELIVERY DEVICES 48
TABLE 18 INSULIN DRUG AND DELIVERY DEVICE PIPELINE PRODUCTS 51
TABLE 19 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE,

THROUGH 2018 ($ MILLIONS) 58
TABLE 20 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY TYPE, 2012 (%) 59
TABLE 21 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION,
THROUGH 2018 ($ MILLIONS) 62
TABLE 22 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARE BY REGION, 2012
(%) 63
TABLE 23 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH 2018
($ MILLIONS) 65
TABLE 24 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 66
TABLE 25 GLOBAL INSULIN PEN MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 68
TABLE 26 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 69
TABLE 27 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 71
TABLE 28 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 72
TABLE 29 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION,
THROUGH 2018 ($ MILLIONS) 76
TABLE 30 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION,
2012 (%) 77
TABLE 31 GLOBAL INSULIN SYRINGE MARKET BY TYPE, THROUGH 2018 ($ MILLIONS) 82
TABLE 32 INSULIN SYRINGE MARKET SHARES BY TYPE, 2012 (%) 83
TABLE 33 GLOBAL INSULIN SYRINGE AND VIAL MARKET, THROUGH 2018 ($
MILLIONS) 84
TABLE 34 INSULIN SYRINGE AND VIAL MARKET SHARES BY TYPE, 2012 (%) 85
TABLE 35 GLOBAL INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 87
TABLE 36 GLOBAL U-100 INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 88
TABLE 37 GLOBAL U-40 INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 89
TABLE 38 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH 2018
($ MILLIONS) 90
TABLE 39 INSULIN SYRINGE MARKET SHARES BY REGION, 2012 (%) 91
TABLE 40 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 92
TABLE 41 INSULIN SYRINGE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS) 95
TABLE 42 INSULIN SYRINGE MARKET SHARES BY APPLICATION, 2012 (%) 96
TABLE 43 INSULIN SYRINGE AND VIAL MARKET BY APPLICATION, THROUGH 2018 ($
MILLIONS) 98
TABLE 44 INSULIN SYRINGE AND VIAL MARKET SHARES BY APPLICATION, 2012 (%) 99
TABLE 45 LEADING MANUFACTURERS AND SUPPLIERS OF INSULIN SYRINGES AND
VIALS 100
TABLE 46 INSULIN SYRINGE MANUFACTURER MARKET SHARES, 2012 (%) 101
TABLE 47 INSULIN SYRINGE AND VIAL MANUFACTURER MARKET SHARES, 2012 (%) 102
TABLE 48 GLOBAL INSULIN PEN MARKET BY TYPE, THROUGH 2018 ($ MILLIONS) 106
TABLE 49 INSULIN PEN MARKET SHARES BY TYPE, 2012 (%) 107
TABLE 50 GLOBAL INSULIN PEN MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 109
TABLE 51 GLOBAL DURABLE OR REUSABLE INSULIN PEN MARKET BY REGION,

THROUGH 2018 ($ MILLIONS) 111
TABLE 52 GLOBAL DISPOSABLE INSULIN PEN MARKET BY REGION, THROUGH 2018
($ MILLIONS) 113
TABLE 53 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 114
TABLE 54 INSULIN PEN MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS) 117
TABLE 55 INSULIN PEN MARKET SHARES BY APPLICATION, 2012 (%) 118
TABLE 56 LEADING INSULIN PEN MANUFACTURERS AND SUPPLIERS 119
TABLE 57 INSULIN PEN MANUFACTURER MARKET SHARES, 2012 (%) 120
TABLE 58 GLOBAL INSULIN PUMP MARKET BY TYPE, THROUGH 2018 ($ MILLIONS) 125
TABLE 59 INSULIN PUMP MARKET SHARES BY TYPE, 2012 (%) 126
TABLE 60 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 128
TABLE 61 GLOBAL INSULIN PUMPS WITH TUBING MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 131
TABLE 62 GLOBAL TUBELESS INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 133
TABLE 63 GLOBAL IMPLANTABLE INSULIN PUMP MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 136
TABLE 64 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 137
TABLE 65 GLOBAL INSULIN PUMP MARKET BY APPLICATION, THROUGH 2018 ($
MILLIONS) 141
TABLE 66 INSULIN PUMP MARKET SHARES BY APPLICATION, 2012 (%) 142
TABLE 67 LEADING MANUFACTURERS AND SUPPLIERS OF INSULIN PUMPS 143
TABLE 68 INSULIN PUMP MANUFACTURER MARKET SHARES, 2012 (%) 144
TABLE 69 U.S. PATENTS, JANUARY 2009–MARCH 2013 (%) 147
TABLE 70 U.S. INSULIN PATENTS BY TYPE, JANUARY 2009–MARCH 2013 148
TABLE 71 U.S. PATENTS BY COMPANY, JANUARY 2009–MARCH 2013 149
TABLE 72 U.S. PATENTS BY COUNTRY, JANUARY 2009–MARCH 2013 151
HLC149A - Global Markets for Emerging Insulin Drug and Delivery Technologies
Copyright © BCC Research, Wellesley MA USA, Website: www.bccresearch.com
TABLE HEADING PAGE NO.
TABLE 73 U.S. PATENTS BY ASSIGNEE, JANUARY 2009–MARCH 2013 152

LIST OF FIGURES

SUMMARY FIGURE GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET,
2011-2018 ($ MILLIONS) 8
FIGURE 1 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE,
2011-2018 ($ MILLIONS) 59
FIGURE 2 INSULIN DRUG AND DEVICE MARKET SHARES BY TYPE, 2012 (%) 60
FIGURE 3 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION,
2011–2018 ($ MILLIONS) 63
FIGURE 4 INSULIN DRUG AND DEVICE MARKET SHARE BY REGION, 2012 (%) 63
FIGURE 5 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, 2011-2018 ($
MILLIONS) 65
FIGURE 6 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 66
FIGURE 7 GLOBAL INSULIN PEN MARKET BY REGION, 2011–2018 ($ MILLIONS) 68
FIGURE 8 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 69
FIGURE 9 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 72
FIGURE 10 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 72
FIGURE 11 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION,
2011–2018 ($ MILLIONS) 76
FIGURE 12 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION,
2012 (%) 77

FIGURE 13 GLOBAL INSULIN SYRINGE MARKET BY TYPE, 2011–2018 ($ MILLIONS) 82
FIGURE 14 INSULIN SYRINGE MARKET SHARES BY TYPE, 2012 (%) 83
FIGURE 15 GLOBAL INSULIN SYRINGE AND VIAL MARKET, 2011–2018 ($ MILLIONS) 84
FIGURE 16 INSULIN SYRINGE AND VIAL MARKET SHARES BY TYPE, 2012 (%) 85
FIGURE 17 GLOBAL INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 87
FIGURE 18 GLOBAL U-100 INSULIN SYRINGE MARKET BY REGION, 2011–2018 ($
MILLIONS) 88
FIGURE 19 GLOBAL U-40 INSULIN SYRINGE MARKET BY REGION, 2011–2018 ($
MILLIONS) 89
FIGURE 20 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 91
FIGURE 21 INSULIN SYRINGE MARKET SHARES BY REGION, 2012 (%) 91
FIGURE 22 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 92
FIGURE 23 INSULIN SYRINGE MARKET BY APPLICATION, 2011–2018 ($ MILLIONS) 96
FIGURE 24 INSULIN SYRINGE MARKET SHARES BY APPLICATION, 2012 (%) 96
FIGURE 25 INSULIN SYRINGE AND VIAL MARKET BY APPLICATION, 2011–2018 ($
MILLIONS) 98
FIGURE 26 INSULIN SYRINGE AND VIAL MARKET SHARES BY APPLICATION, 2012 (%) 99
FIGURE 27 INSULIN SYRINGE MANUFACTURER MARKET SHARES, 2012 (%) 101

FIGURE 28 INSULIN SYRINGE AND VIAL MANUFACTURER MARKET SHARES, 2012 (%) 103
FIGURE 29 GLOBAL INSULIN PEN MARKET BY TYPE, THROUGH 2018 ($ MILLIONS) 106
FIGURE 30 INSULIN PEN MARKET SHARES BY TYPE, 2012 (%) 107
FIGURE 31 GLOBAL INSULIN PEN MARKET BY REGION, 2011–2018 ($ MILLIONS) 110
FIGURE 32 GLOBAL DURABLE OR REUSABLE INSULIN PEN MARKET BY REGION,
THROUGH 2018 ($ MILLIONS) 111
FIGURE 33 GLOBAL DISPOSABLE INSULIN PEN MARKET BY REGION, THROUGH 2018
($ MILLIONS) 114
FIGURE 34 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 114
FIGURE 35 INSULIN PEN MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS) 117
FIGURE 36 INSULIN PEN MARKET SHARES BY APPLICATION, 2012 (%) 118
FIGURE 37 INSULIN PEN MANUFACTURER MARKET SHARES, 2012 (%) 121
FIGURE 38 GLOBAL INSULIN PUMP MARKET BY TYPE, THROUGH 2018 ($ MILLIONS) 126
FIGURE 39 INSULIN PUMP MARKET SHARES BY TYPE, 2012 (%) 126
FIGURE 40 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 128
FIGURE 41 GLOBAL INSULIN PUMPS WITH TUBING MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 131
FIGURE 42 GLOBAL TUBELESS INSULIN PUMP MARKET BY REGION, 2011–2018 ($
MILLIONS) 133
FIGURE 43 GLOBAL IMPLANTABLE INSULIN PUMP MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 136
FIGURE 44 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 137
FIGURE 45 GLOBAL INSULIN PUMP MARKET BY APPLICATION, THROUGH 2018 ($
MILLIONS) 141
FIGURE 46 INSULIN PUMP MARKET SHARES BY APPLICATION, 2012 (%) 142
FIGURE 47 INSULIN PUMP MANUFACTURER MARKET SHARES, 2012 (%) 144
FIGURE 48 U.S. PATENTS, JANUARY 2009–MARCH 2013 (%) 147
FIGURE 49 U.S. INSULIN PATENTS BY TYPE, JANUARY 2009–MARCH 2013 148
FIGURE 50 U.S. PATENTS BY COUNTRY, JANUARY 2009–MARCH 2013 152
FIGURE 51 U.S. PATENTS BY ASSIGNEE, JANUARY 2009–MARCH 2013 152

To order this report:
Medical_Equipment_and_Supply Industry: Global Markets for Emerging Insulin Drug and Delivery Technologies

Contact Clare: clare@reportlinker.com  
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker